Candidal sepsis
ICD-10 B40.7 is a billable code used to indicate a diagnosis of candidal sepsis.
Candidal sepsis is a severe systemic infection caused by Candida species, a type of yeast that can lead to significant morbidity and mortality, particularly in immunocompromised patients. This condition arises when Candida enters the bloodstream, often following a breach in mucosal barriers or through invasive medical procedures. Patients at high risk include those with weakened immune systems due to conditions such as HIV/AIDS, cancer, diabetes, or those undergoing immunosuppressive therapies. Clinical manifestations may include fever, chills, hypotension, and multi-organ dysfunction, necessitating prompt recognition and treatment. Diagnosis typically involves blood cultures, which may take time to yield results, complicating timely management. Antifungal therapy, primarily with agents such as fluconazole, caspofungin, or amphotericin B, is critical for treatment. The choice of antifungal depends on the severity of the infection, the patient's clinical status, and local resistance patterns. Early intervention is crucial to improve outcomes, as delays in treatment can lead to increased mortality rates.
Detailed clinical notes on the patient's history, risk factors, and response to treatment.
Patients with recurrent infections, those undergoing chemotherapy, or with chronic illnesses.
Ensure that all antifungal treatments and their indications are clearly documented.
Comprehensive records of vital signs, organ function, and treatment protocols.
Management of septic shock and multi-organ failure in critically ill patients.
Document the timeline of sepsis progression and interventions taken.
Used when rapid identification of Candida is needed in a septic patient.
Document the reason for testing and the clinical context.
Infectious disease specialists should ensure comprehensive documentation of the patient's history.
The primary treatment for candidal sepsis includes antifungal medications such as fluconazole, caspofungin, or amphotericin B, depending on the severity of the infection and the patient's clinical status.
